# Royalty Pharma plc > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:52361b75-63da-4409-82b1-fed172f2f056 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/royalty-pharma-plc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 22 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-15T04:45:20.170332+00:00 | | Last reviewed | 2026-10-15T04:45:20.170332+00:00 | ## Identity - Legal name: Royalty Pharma plc - Display name: Royalty Pharma plc ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T02:35:18.569654+00:00 | | Completeness | 0.409 | | Record Quality | 0.835 | | Directors | 5 | | Committees | 5 | | Governance events | 14 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Catherine Engelbert: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (member). claim_id=alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:leadership_role:6 - David Hodgson: Director. Status: current. Independent: true. Since: 2022-01-01. Committees: Audit (member); Audit; Compensation · Chair (member); Compensation (chair). claim_id=alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:leadership_role:7 - Gregory Norden: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (chair); Audit · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:leadership_role:8 - Pablo Legorreta: Director. Status: current. Independent: false. Since: 2020-01-01. claim_id=alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:leadership_role:9 - Vlad Coric, M.D.: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:leadership_role:10 ## Committees - Audit (audit). Chair: Gregory Norden. Members: Gregory Norden (chair, current); Catherine Engelbert (member, current); David Hodgson (member, current). committee_id=alpha:committee:royalty-pharma-plc:audit - Audit · Chair; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Gregory Norden (member, current). committee_id=alpha:committee:royalty-pharma-plc:audit-chair-nominating-and-governance - Audit; Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: David Hodgson (member, current). committee_id=alpha:committee:royalty-pharma-plc:audit-compensation-chair - Compensation (compensation). Chair: David Hodgson. Members: David Hodgson (chair, current). committee_id=alpha:committee:royalty-pharma-plc:compensation - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: Gregory Norden (member, current). committee_id=alpha:committee:royalty-pharma-plc:nominating-and-governance ## Executive leadership - Arthur McGivern: General Counsel [GC]. Status: current. claim_id=alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:leadership_role:11 - Christopher Hite: Executive Vice President and Vice Chairman. Status: current. claim_id=alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:leadership_role:12 - Pablo Legorreta: Chairman of the Board, Director and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:leadership_role:13 - Terrance Coyne: Executive Vice President and Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:leadership_role:14 ## Governance events - GC_CHANGED: Arthur McGivern executive of Royalty Pharma plc, effective 2026-02-11. Effective: 2026-02-11. Detected: 2026-10-15T04:45:20.170332+00:00. event_id=alpha:event:transition:1jslq8114ry86d - EXECUTIVE_APPOINTED: Christopher Hite executive of Royalty Pharma plc, effective 2026-02-11. Effective: 2026-02-11. Detected: 2026-10-15T04:45:20.170332+00:00. event_id=alpha:event:transition:1x46hfmwfkqe2 - CEO_CHANGED: Pablo Legorreta executive of Royalty Pharma plc, effective 2026-02-11. Effective: 2026-02-11. Detected: 2026-10-15T04:45:20.170332+00:00. event_id=alpha:event:transition:1v69wwsusmf3o - CFO_CHANGED: Terrance Coyne executive of Royalty Pharma plc, effective 2026-02-11. Effective: 2026-02-11. Detected: 2026-10-15T04:45:20.170332+00:00. event_id=alpha:event:transition:1lcgz5m1oip6ni - DIRECTOR_APPOINTED: Vlad Coric, M.D. seat on Royalty Pharma plc, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-15T04:45:20.170332+00:00. event_id=alpha:event:transition:xk69ms1nwf2r4 - DIRECTOR_APPOINTED: David Hodgson seat on Royalty Pharma plc, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-15T04:45:20.170332+00:00. event_id=alpha:event:transition:8ux7l98efc15 - COMMITTEE_CREATED: Audit; Compensation · Chair committee of Royalty Pharma plc, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-15T04:45:20.170332+00:00. event_id=alpha:event:transition:elldo91ty7vy1 - COMMITTEE_MEMBER_ADDED: David Hodgson member of Audit; Compensation · Chair, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-15T04:45:20.170332+00:00. event_id=alpha:event:transition:1kfiade1w40ots - DIRECTOR_APPOINTED: Catherine Engelbert seat on Royalty Pharma plc, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-15T04:45:20.170332+00:00. event_id=alpha:event:transition:ykjzte642uqi - DIRECTOR_APPOINTED: Gregory Norden seat on Royalty Pharma plc, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-15T04:45:20.170332+00:00. event_id=alpha:event:transition:1yx0s7cnp2gek - DIRECTOR_APPOINTED: Pablo Legorreta seat on Royalty Pharma plc, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-15T04:45:20.170332+00:00. event_id=alpha:event:transition:80oqcd1a9341h - COMMITTEE_MEMBER_ADDED: Catherine Engelbert member of Audit, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-15T04:45:20.170332+00:00. event_id=alpha:event:transition:nnaa8ckhpvvq - COMMITTEE_CREATED: Audit · Chair; Nominating and Governance committee of Royalty Pharma plc, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-15T04:45:20.170332+00:00. event_id=alpha:event:transition:y827py1d3svuw - COMMITTEE_MEMBER_ADDED: Gregory Norden member of Audit · Chair; Nominating and Governance, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-15T04:45:20.170332+00:00. event_id=alpha:event:transition:wuavji1azfwqe ## Scoped resources - `alpha://company/royalty-pharma-plc` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record - `alpha://company/royalty-pharma-plc/identity` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=identity - `alpha://company/royalty-pharma-plc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=corporate-structure - `alpha://company/royalty-pharma-plc/board` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=board - `alpha://company/royalty-pharma-plc/committees` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=committees - `alpha://company/royalty-pharma-plc/leadership` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=leadership - `alpha://company/royalty-pharma-plc/ownership` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=ownership - `alpha://company/royalty-pharma-plc/financials` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=financials - `alpha://company/royalty-pharma-plc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=capital-structure - `alpha://company/royalty-pharma-plc/compensation` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=compensation - `alpha://company/royalty-pharma-plc/governance` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=governance - `alpha://company/royalty-pharma-plc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=shareholder-governance - `alpha://company/royalty-pharma-plc/audit` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=audit - `alpha://company/royalty-pharma-plc/legal` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=legal - `alpha://company/royalty-pharma-plc/risk` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=risk - `alpha://company/royalty-pharma-plc/cyber` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=cyber - `alpha://company/royalty-pharma-plc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=ai-governance - `alpha://company/royalty-pharma-plc/agents` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=agents - `alpha://company/royalty-pharma-plc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=ecosystem - `alpha://company/royalty-pharma-plc/events` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=events - `alpha://company/royalty-pharma-plc/relationships` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=relationships - `alpha://company/royalty-pharma-plc/assessments` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=assessments - `alpha://company/royalty-pharma-plc/evidence` (contract): https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:gregory-norden","name":"Gregory Norden"},"source_id":"board_seats"}` - Claim alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:catherine-engelbert","name":"Catherine Engelbert"},"source_id":"board_seats"}` - Claim alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:david-hodgson","name":"David Hodgson"},"source_id":"board_seats"}` - Claim alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:david-hodgson","name":"David Hodgson"},"source_id":"board_seats"}` - Claim alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:gregory-norden","name":"Gregory Norden"},"source_id":"board_seats"}` ## Leadership - Catherine Engelbert: Director, Audit. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e021c23c7bd560137e2bbc66332ea014e88beb22b05e75ce7fac92e2d7b857f7. - David Hodgson: Director, Audit; Compensation · Chair. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:leadership_role:7. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e021c23c7bd560137e2bbc66332ea014e88beb22b05e75ce7fac92e2d7b857f7. - Gregory Norden: Director, Audit · Chair; Nominating and Governance. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:leadership_role:8. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e021c23c7bd560137e2bbc66332ea014e88beb22b05e75ce7fac92e2d7b857f7. - Pablo Legorreta: Director. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:leadership_role:9. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e021c23c7bd560137e2bbc66332ea014e88beb22b05e75ce7fac92e2d7b857f7. - Vlad Coric, M.D.: Director. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:leadership_role:10. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e021c23c7bd560137e2bbc66332ea014e88beb22b05e75ce7fac92e2d7b857f7. - Arthur McGivern: General Counsel. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:leadership_role:11. Valid from: 2026-02-11. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:46f466c145a6f4561c39e1d47b3dda5343264b1cf17411ddfa1973745fce9413. - Christopher Hite: Executive Vice President and Vice Chairman. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:leadership_role:12. Valid from: 2026-02-11. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:32fdb41ecd90c2bf5b37736ef3269e114d86ee7cb712247f6773cead527f4e6b. - Pablo Legorreta: Chairman of the Board, Director and Chief Executive Officer. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:leadership_role:13. Valid from: 2026-02-11. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fc239e7f7d25570af850be68f8f96d34964d86026f437b073382d6dce23373a9. - Terrance Coyne: Executive Vice President and Chief Financial Officer. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:leadership_role:14. Valid from: 2026-02-11. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7c957b70fb9f13dac90b192ae1ddb29380147c09225a7c3dd4548db6f3211f1b. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Gregory Norden; Members Gregory Norden (Chair); Catherine Engelbert; David Hodgson. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:committee_record:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e1dd164a848b2c7ec7f14ef97c50d743a992f57e8da6f49d1b4e28b34da58d02. - Compensation: Chair David Hodgson; Members David Hodgson (Chair). Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:committee_record:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e1dd164a848b2c7ec7f14ef97c50d743a992f57e8da6f49d1b4e28b34da58d02. - Nominating and Governance: Chair not stated; Members Gregory Norden. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e1dd164a848b2c7ec7f14ef97c50d743a992f57e8da6f49d1b4e28b34da58d02. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Royalty Pharma plc. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:485f047cbf0e2499a892894e7aabc17a147c8938cccf11ca935d7362d5731991. ## Entity Status - Public listing published. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:485f047cbf0e2499a892894e7aabc17a147c8938cccf11ca935d7362d5731991. ## Published Fact - US. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:485f047cbf0e2499a892894e7aabc17a147c8938cccf11ca935d7362d5731991. - Healthcare. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:485f047cbf0e2499a892894e7aabc17a147c8938cccf11ca935d7362d5731991. ## Committee Appointment - Gregory Norden: chair, Audit. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e1dd164a848b2c7ec7f14ef97c50d743a992f57e8da6f49d1b4e28b34da58d02. - Catherine Engelbert: member, Audit. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e1dd164a848b2c7ec7f14ef97c50d743a992f57e8da6f49d1b4e28b34da58d02. - David Hodgson: member, Audit. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e1dd164a848b2c7ec7f14ef97c50d743a992f57e8da6f49d1b4e28b34da58d02. - David Hodgson: chair, Compensation. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e1dd164a848b2c7ec7f14ef97c50d743a992f57e8da6f49d1b4e28b34da58d02. - Gregory Norden: member, Nominating and Governance. Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e1dd164a848b2c7ec7f14ef97c50d743a992f57e8da6f49d1b4e28b34da58d02. ## Security Listing - RPRX (NASDAQ). Claim: alpha:claim:company:52361b75-63da-4409-82b1-fed172f2f056:security_listing:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:485f047cbf0e2499a892894e7aabc17a147c8938cccf11ca935d7362d5731991. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:485f047cbf0e2499a892894e7aabc17a147c8938cccf11ca935d7362d5731991: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/royalty-pharma-plc). - alpha:projection-evidence:document:e021c23c7bd560137e2bbc66332ea014e88beb22b05e75ce7fac92e2d7b857f7: [Royalty Pharma plc DEF 14A 2026-04-10](https://www.sec.gov/Archives/edgar/data/1802768/000114036126014239/ny20066979x1_def14a.htm). - alpha:projection-evidence:document:46f466c145a6f4561c39e1d47b3dda5343264b1cf17411ddfa1973745fce9413: [RPRX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1802768/000180276826000003/rprx-20251231.htm). - alpha:projection-evidence:document:32fdb41ecd90c2bf5b37736ef3269e114d86ee7cb712247f6773cead527f4e6b: [RPRX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1802768/000180276826000003/rprx-20251231.htm). - alpha:projection-evidence:document:fc239e7f7d25570af850be68f8f96d34964d86026f437b073382d6dce23373a9: [RPRX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1802768/000180276826000003/rprx-20251231.htm). - alpha:projection-evidence:document:7c957b70fb9f13dac90b192ae1ddb29380147c09225a7c3dd4548db6f3211f1b: [RPRX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1802768/000180276826000003/rprx-20251231.htm). - alpha:projection-evidence:e1dd164a848b2c7ec7f14ef97c50d743a992f57e8da6f49d1b4e28b34da58d02: [Audit](https://www.sec.gov/Archives/edgar/data/1802768/000114036126014239/ny20066979x1_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/royalty-pharma-plc) - [Public Markdown](https://registry.alpha.ac/companies/royalty-pharma-plc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/royalty-pharma-plc?format=jsonld) - MCP resource: `alpha://companies/royalty-pharma-plc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T02:35:18.361011+00:00; recorded 2026-10-16T02:35:18.361011+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.